• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用深共熔溶剂提高阿托伐他汀的溶解度

Solubility improvement of atorvastatin using deep eutectic solvents.

作者信息

Wardhana Yoga Windhu, Kurniawansyah Insan Sunan, Rusdiana Taofik

机构信息

Department of Pharmaceutics and Pharmaceuticals Technology, Faculty of Pharmacy, Universitas Padjadjaran (UNPAD), Jatinangor, Indonesia.

Study Center of Drug Discovery and Drug Development, Faculty of Pharmacy, Universitas Padjadjaran (UNPAD), Jatinangor, Indonesia.

出版信息

J Adv Pharm Technol Res. 2025 Jul-Sep;16(3):144-150. doi: 10.4103/JAPTR.JAPTR_337_24. Epub 2025 Aug 9.

DOI:10.4103/JAPTR.JAPTR_337_24
PMID:40901447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12401521/
Abstract

Deep eutectic solvents (DESs) in pharmaceutical investigations are still largely unknown in terms of safety, environmental acceptability, and practical use. The investigation focus is primarily of attempts to improve solubility is examined using the co-crystallization approach, which follows similar principles to the production of eutectic mixtures. We will look into the eutectic mixture interaction between selected coformers (nicotinamide [NA], isonicotinamide, and citric acid as acceptors of hydrogen bond and atorvastatin calcium trihydrate [ATCH] as donors of hydrogen bond in the DES system, assisted by propylene glycol [PG]). The study found that the optimum interaction in the DES system for ATCH is using NA in PG as a carrier, with evaluation by polarization microscopy, Fourier transform infrared spectroscopy (FT-IR), and differential scanning calorimetry (DSC), verifying that the drug and the DES components have formed H-bonds. H-bond interactions had been recognized through FT-IR and DSC, revealing that the DESs with NA coformer can increase ATCH solubility, as shown in the phase diagram. The increase in solubility was fairly considerable, allowing ATCH to dissolve at high concentrations in DESs, with a solubility of 0.158 ± 0.098 mg/mL compared to 0.000597 ± 0.003 mg/mL in water. Thus, it is obtainable to conclude that among the selected coformers, the DES system with the potential for improving the solubility of ATCH is DESs with NA coformer assisted by PG.

摘要

在药物研究中,深共晶溶剂(DESs)在安全性、环境可接受性和实际应用方面仍 largely unknown。研究重点主要是尝试采用共结晶方法来提高溶解度,该方法遵循与共晶混合物生产相似的原理。我们将研究选定的共形成物(烟酰胺[NA]、异烟酰胺和柠檬酸作为氢键受体,阿托伐他汀钙三水合物[ATCH]作为DES系统中的氢键供体,并由丙二醇[PG]辅助)之间的共晶混合物相互作用。研究发现,在DES系统中,ATCH的最佳相互作用是使用PG中的NA作为载体,并通过偏光显微镜、傅里叶变换红外光谱(FT-IR)和差示扫描量热法(DSC)进行评估,证实药物与DES成分形成了氢键。通过FT-IR和DSC识别出了氢键相互作用,这表明含有NA共形成物的DESs可以增加ATCH的溶解度,如相图所示。溶解度的增加相当可观,使得ATCH能够在DESs中高浓度溶解,其溶解度为0.158±0.098mg/mL,而在水中为0.000597±0.003mg/mL。因此,可以得出结论,在选定的共形成物中,具有提高ATCH溶解度潜力的DES系统是由PG辅助的含有NA共形成物的DESs。

相似文献

1
Solubility improvement of atorvastatin using deep eutectic solvents.使用深共熔溶剂提高阿托伐他汀的溶解度
J Adv Pharm Technol Res. 2025 Jul-Sep;16(3):144-150. doi: 10.4103/JAPTR.JAPTR_337_24. Epub 2025 Aug 9.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
4
Potential use of deep eutectic solvents based on sugar as green separation media for the acidic gases capture process from the gas mixtures: molecular dynamics simulation and COSMO-RS insights.基于糖的深共熔溶剂作为从混合气体中捕获酸性气体过程的绿色分离介质的潜在应用:分子动力学模拟和COSMO-RS见解
J Mol Model. 2025 Jul 14;31(8):210. doi: 10.1007/s00894-025-06430-8.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Understanding the relationship between deep eutectic solvent polarity and the structural integrity and stability of hemoglobin: A balance between hydrophobicity and hydrophilicity.理解深共熔溶剂极性与血红蛋白结构完整性和稳定性之间的关系:疏水性和亲水性之间的平衡。
Int J Biol Macromol. 2025 Jul 22;321(Pt 1):146238. doi: 10.1016/j.ijbiomac.2025.146238.
7
Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES).共晶溶液在治疗中的应用:治疗性深共晶溶剂(TheDES)的综合综述。
Drug Dev Ind Pharm. 2024 May;50(5):387-400. doi: 10.1080/03639045.2024.2345131. Epub 2024 Apr 24.
8
Molecularly designed deep eutectic solvents based on choline for site-specific delivery of luteolin in the oral cavity.基于胆碱的分子设计型低共熔溶剂用于木犀草素在口腔中的定点递送
Int J Pharm. 2025 Oct 15;683:126061. doi: 10.1016/j.ijpharm.2025.126061. Epub 2025 Aug 14.
9
Effect of food matrices on AFB recovery by lateral flow immunoassay with deep eutectic solvents as a green alternative to conventional extraction.以深共熔溶剂作为传统萃取的绿色替代物,食品基质对基于侧流免疫分析法的黄曲霉毒素B1回收率的影响
Mikrochim Acta. 2025 Aug 29;192(9):627. doi: 10.1007/s00604-025-07488-0.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Significant progress in improving Atorvastatin dissolution rate: Physicochemical characterization and stability assessment of self-dispersible Atorvastatin/Tween 80® nanocrystals formulated through wet milling and freeze-drying.显著提高阿托伐他汀溶出度的进展:通过湿磨和冷冻干燥制备自分散阿托伐他汀/聚山梨酯 80®纳米晶体的理化特性表征和稳定性评估。
Int J Pharm. 2024 Jan 25;650:123720. doi: 10.1016/j.ijpharm.2023.123720. Epub 2023 Dec 16.
2
Machine learning models for hydrogen bond donor and acceptor strengths using large and diverse training data generated by first-principles interaction free energies.利用第一性原理相互作用自由能生成的大量多样训练数据构建的氢键供体和受体强度机器学习模型。
J Cheminform. 2019 Sep 11;11(1):59. doi: 10.1186/s13321-019-0381-4.
3
Investigation of electropolishing characteristics of tungsten in eco-friendly sodium hydroxide aqueous solution.在环保型氢氧化钠水溶液中钨的电解抛光特性研究。
Adv Manuf. 2020;8(3):265-278. doi: 10.1007/s40436-020-00309-y. Epub 2020 May 26.
4
Deep eutectic solvents for pharmaceutical formulation and drug delivery applications.用于药物制剂和药物输送应用的深共晶溶剂。
Pharm Dev Technol. 2020 Sep;25(7):779-796. doi: 10.1080/10837450.2020.1735414. Epub 2020 Mar 9.
5
Application of Differential Scanning Calorimetry (DSC) and Modulated Differential Scanning Calorimetry (MDSC) in Food and Drug Industries.差示扫描量热法(DSC)和调制差示扫描量热法(MDSC)在食品和制药行业中的应用。
Polymers (Basel). 2019 Dec 18;12(1):5. doi: 10.3390/polym12010005.
6
A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.纯活性药物成分与治疗性低共熔溶剂的比较:溶解度和渗透性研究。
Eur J Pharm Biopharm. 2017 May;114:296-304. doi: 10.1016/j.ejpb.2017.02.003. Epub 2017 Feb 9.
7
Investigation on drug solubility enhancement using deep eutectic solvents and their derivatives.使用低共熔溶剂及其衍生物提高药物溶解度的研究。
Int J Pharm. 2016 May 30;505(1-2):283-8. doi: 10.1016/j.ijpharm.2016.04.018. Epub 2016 Apr 11.
8
PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles.载冻干阿托伐他汀钙的聚己内酯纳米粒的药代动力学-药效学评价
Int J Pharm. 2016 May 17;504(1-2):70-9. doi: 10.1016/j.ijpharm.2016.03.045. Epub 2016 Mar 25.
9
Recent advances in co-amorphous drug formulations.共无定形药物制剂的最新进展。
Adv Drug Deliv Rev. 2016 May 1;100:116-25. doi: 10.1016/j.addr.2015.12.009. Epub 2016 Jan 21.
10
Dissolution enhancement of atorvastatin calcium by co-grinding technique.采用共研磨技术增强阿托伐他汀钙的溶出度。
Drug Deliv Transl Res. 2016 Aug;6(4):380-91. doi: 10.1007/s13346-015-0271-x.